DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Forward Printable StoryPrint Comment




More HCB News

TIAA Bank acquires $1.5 billion portfolio from GE Capital's HEF business Portfolio of healthcare equipment leases and loans

Driving premium platform valuations for future growth The radiology M&A market is red hot, help investors see the value in your business

Beyond bright and shiny: Practical applications for AI in healthcare Top takeaways from a panel on hospital-wide transformation

DR to meet DNA: The future of X-ray Digital X-ray will soon capture motion and provide a vast array of new insights to diagnostic imaging

Life Image and Dicom Systems partner on interoperability Combine Dicom Systems' Unifier with Life Image global data-sharing network

TeamBest companies to acquire ABT Molecular Imaging, launch Best ABT Bringing greater expertise to smaller cyclotron technology

Philips integrates its IntelliSpace Enterprise Edition, PerformanceBridge solutions ahead of RSNA Will be rolled out at Jackson Health System

Screenings reduce risk of breast cancer death by 47-60 percent: study New research confirms what most physicians have long believed

Nonresident medical device sellers operating in CA may face fines with few options for compliance 30 states do not issue the required license

Algorithm could bridge skill gap in detecting heart murmurs for non-cardiologists Outperformed majority of cardiologists in a study

SHINE Medical and Phoenix Nuclear achieve key technical milestone with 24-hour accelerator test

Press releases may be edited for formatting or style
MONONA, Wis. - SHINE Medical Technologies and Phoenix Nuclear Labs (PNL) announced today that they successfully operated their second-generation neutron driver prototype for 24 consecutive hours with 99% uptime. Completion of this milestone is an important demonstration of the reliability and robustness of the PNL neutron driver, which is a key enabling technology for SHINE's isotope production facility.

"I'm very excited PNL has demonstrated the reliability of their accelerator technology. Their team continues their strong track record of achievement, having reached this important milestone sooner than expected," said Greg Piefer, CEO of SHINE Medical.

Story Continues Below Advertisement

Questions to ask and things to consider about MRI coil repair processes

What to Expect from MRI Coil Repairs that Meet Clinical Expectations and Drive ROI. Click for A Guideline of Standards to Expect and Demand for Sustainable MRI Coil Repairs

"This specific accomplishment proves something we have been confident in all along-that the accelerator technology can work reliably at the power levels needed by our plant for extended periods of time. "We look forward to continued collaboration with PNL as we complete the transition of the accelerator system from demonstration to production."

SHINE is working to become the leading US supplier of molybdenum-99, a radioactive isotope that enables more than 80,000 medical imaging procedures every day to diagnose heart disease and cancer. At the core of the SHINE process for producing moly-99 is a particle accelerator-based, high-yield neutron driver manufactured by PNL. The SHINE facility, scheduled to begin commercial production of moly-99 in 2017 in Janesville, WI, will operate up to eight PNL drivers simultaneously to supply more than half of total US moly-99 demand.

"PNL is thrilled to have the opportunity to support SHINE's mission to produce the life-saving medical isotopes needed by so many Americans every day. We look forward to continuing our strong relationship and providing SHINE with a great product," said Ross Radel, President of PNL. "The credit for this success really goes to our dedicated engineering team. They have been working around the clock to complete this demonstration, and we could not be happier with the performance of our technology."

High reliability and uptime for the PNL neutron driver is important to SHINE Medical's goal to provide a reliable, domestic supply of moly-99 to the US. Demonstrating long-term operation of the PNL neutron driver with very high up-time provides important validation of SHINE's moly-99 production process. The successful test of the PNL driver was completed on July 31 and August 1 in Monona, WI. Testing of the second-generation neutron driver prototype will continue over the next several months.
  Pages: 1 - 2 >>


You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.